TY  - JOUR
AU  - Meixner, Eva
AU  - Arians, Nathalie
AU  - Bougatf, Nina
AU  - Hoeltgen, Line
AU  - König, Laila
AU  - Lang, Kristin
AU  - Domschke, Christoph
AU  - Wallwiener, Markus
AU  - Lischalk, Jonathan W
AU  - Kommoss, Felix K F
AU  - Debus, Jürgen
AU  - Hörner-Rieber, Juliane
TI  - Vaginal cancer treated with curative radiotherapy with or without concomitant chemotherapy: oncologic outcomes and prognostic factors.
JO  - Tumori journal
VL  - 109
IS  - 1
SN  - 2038-2529
CY  - Thousand Oaks, Calif.
PB  - Sage Publishing
M1  - DKFZ-2021-02396
SP  - 112-120
PY  - 2023
N1  - 2023 Feb;109(1):112-120
AB  - Vaginal cancer is a rare disease for which prospective randomized trials do not exist. We aimed to assess survival outcomes, patterns of recurrence, prognostic factors, and toxicity in the curative treatment using image-guided radiotherapy (RT).In this retrospective review, we identified 53 patients who were treated at a single center with external beam radiotherapy and brachytherapy with or without concomitant chemotherapy from 2000 to 2021.With a median follow-up of 64.5 months, the Kaplan-Meier 2-, 5-, and 7-year overall survival (OS) was found to be 74.8
KW  - EQD2 (Other)
KW  - Squamous cell carcinoma of the vagina (Other)
KW  - carbon ions (Other)
KW  - high-dose-rate brachytherapy (Other)
KW  - vaginal neoplasms (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:34724840
DO  - DOI:10.1177/03008916211056369
UR  - https://inrepo02.dkfz.de/record/177263
ER  -